WO2021163915A1 - 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 - Google Patents
含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 Download PDFInfo
- Publication number
- WO2021163915A1 WO2021163915A1 PCT/CN2020/075824 CN2020075824W WO2021163915A1 WO 2021163915 A1 WO2021163915 A1 WO 2021163915A1 CN 2020075824 W CN2020075824 W CN 2020075824W WO 2021163915 A1 WO2021163915 A1 WO 2021163915A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cleansing composition
- mild cleansing
- mild
- skin
- active ingredient
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 145
- 239000004480 active ingredient Substances 0.000 title claims abstract description 80
- 229920006395 saturated elastomer Polymers 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title description 10
- 239000004094 surface-active agent Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 229940079988 potassium cocoyl glycinate Drugs 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 17
- 241000173529 Aconitum napellus Species 0.000 claims description 15
- 241000213006 Angelica dahurica Species 0.000 claims description 15
- 229940023019 aconite Drugs 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 108700004121 sarkosyl Proteins 0.000 claims description 15
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 15
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 15
- 241001313857 Bletilla striata Species 0.000 claims description 14
- 241000249820 Lipotes vexillifer Species 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
- 244000197580 Poria cocos Species 0.000 claims description 12
- 235000008599 Poria cocos Nutrition 0.000 claims description 12
- 241001442052 Symphytum Species 0.000 claims description 12
- 235000005865 Symphytum officinale Nutrition 0.000 claims description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- -1 lauroyl methylol Chemical class 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- 230000036548 skin texture Effects 0.000 claims description 4
- 238000000638 solvent extraction Methods 0.000 claims description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 241001071917 Lithospermum Species 0.000 claims description 3
- SFUJSVYIFAGAGL-UHFFFAOYSA-N [Na].CCCCCCCCCCCC(=O)OS(=O)(=O)C(C)CO Chemical compound [Na].CCCCCCCCCCCC(=O)OS(=O)(=O)C(C)CO SFUJSVYIFAGAGL-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 2
- 229940083542 sodium Drugs 0.000 claims 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 88
- 238000004140 cleaning Methods 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 17
- 238000001000 micrograph Methods 0.000 description 15
- 238000001556 precipitation Methods 0.000 description 14
- 210000000434 stratum corneum Anatomy 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 238000012423 maintenance Methods 0.000 description 13
- 230000003020 moisturizing effect Effects 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000013461 design Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 description 6
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 description 6
- 239000003599 detergent Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000013022 formulation composition Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 241000092665 Atractylodes macrocephala Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 241000132012 Atractylodes Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 3
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 238000005282 brightening Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- 229940029223 peg-200 hydrogenated glyceryl palmate Drugs 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 230000004215 skin function Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000002300 anti-fibrosis Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000004064 cosurfactant Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 230000003832 immune regulation Effects 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 241001313855 Bletilla Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010925 quality by design Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- KQFAFFYKLIBKDE-UHFFFAOYSA-M sodium;ethanesulfonate Chemical compound [Na+].CCS([O-])(=O)=O KQFAFFYKLIBKDE-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Definitions
- the present invention relates to a mild cleansing composition containing active ingredients close to saturation, saturation, or supersaturation, and a preparation method thereof, and in particular to a kind of composition containing at least one surfactant and at least one close to saturation, saturation, or supersaturation and A cleansing and maintenance composition with active ingredients capable of improving skin texture and a preparation method thereof.
- the skin is the largest natural barrier between the human body and the outside world.
- the goal of skin cleansing is to remove foreign objects in the human environment and the sebum and sweat produced by the human body. Therefore, skin cleansing is the first step to maintain skin health. Take facial cleansing as an example.
- the cleaning principle of detergents can be roughly divided into two types: dissolving and emulsifying dirt (Physicochemical and Engineering Aspects, 74, 169-215 (1993)).
- the cleaning agent used to remove dirt by using the principle of dissolution is difficult to avoid excessive washing of the skin surface, which will damage the skin barrier and cause rough and dry skin after cleaning (Clinics in Dermatology, Volume 14, Issue 1, January-February 1996, Pages 29 -33), it even leads to excessive sebum secretion; the detergents and emulsifiers used to remove the dirt by the principle of emulsification are not easy to completely remove the dirt, so a small amount of small emulsion droplets that are not washed off after emulsification are accumulated on the skin surface On the pores and sweat glands, resulting in unclean feeling, clogged pores, and acne proliferation.
- the timing and method of skin care after cleansing is also a challenge in the lives of ordinary people.
- the timing of personal skin care varies from person to person, but the evaluation of skin care products can be analyzed from two aspects: First, the formula combination of skin care products mainly includes water, oil, emulsifier, stabilizer, various bases and even solvents, etc., due to the basic It is composed of two insoluble oil and water phases and the maximum composition ratio. Therefore, emulsifiers, stabilizers, etc. are required. If other active ingredients are required, they often face various challenges in physical and chemical stability, and the active ingredients The proportion is usually quite low, and it is difficult to improve the aesthetic or clinical effects.
- the absorption of topical skin preparations is mainly affected by the barrier formed by the stratum corneum, which results in limited effects.
- TDDS transdermal delivery system
- the problems to be overcome in the first way of absorption mainly include the acid mantle of the skin (Current Pharmaceutical Design, 2015, Vol. 21, No. 00), and the stratum corneum that causes absorption barriers, both of which block drugs and cosmetics.
- the main obstacle to the absorption of active ingredients is also the main factor that makes it difficult for consumers to achieve the expected maintenance effect when using various skin care products.
- the present invention intends to improve the previous technology that is difficult to clean the skin with a gentle formula and the difficult-to-fit method to maintain the skin, so as to clean the skin at the same time, prevent excessive cleaning, and achieve the initial maintenance effect to enhance the skin function.
- the gentle cleansing composition is provided.
- the active ingredient is combined with a mild surfactant formula in a manner close to saturation, saturation or supersaturation, and a simple manufacturing process is used to make a composition that can clean, avoid excessive cleaning and maintain the skin at the same time, wherein the active ingredient contains Angelica dahurica Extracts of one or more of, Atractylodes, Atractylodes, Bletilla striata, Poria, Aconite, and Comfrey; and surfactants include long-chain betaine, sodium lauroyl sarcosinate, and lauroyl hydroxymethyl A combination of one or more of sodium ethanesulfonate and potassium cocoylglycinate.
- the mild cleansing composition containing active ingredients of the present invention can be used on any skin part of the human body to directly clean the skin and achieve maintenance effects at the same time. Its effect on the skin can be one of the following or a combination of effects, such as: whitening, promoting collagen Protein synthesis, anti-inflammatory, avoiding dry and cracked skin, anti-itch, anti-allergic, anti-aging, anti-oxidation, immune regulation, anti-fibrosis, etc.
- the mild cleansing composition of the present invention containing nearly saturated, saturated, or supersaturated active ingredients
- its individual active ingredients are referenced in the composition of the present invention as landmark and representative ingredients (especially fat-soluble, highly physiologically active
- the saturation of its aqueous solution is Angelica dahurica ⁇ 0.01%, Baiji ⁇ 0.003%, Baizhu ⁇ 0.004%, Bletilla ⁇ 0.006%, Poria ⁇ 0.05%, Aconite ⁇ 0.0002%, and Lithospermum ⁇ 0.01%; therefore, its total saturation concentration About not more than 0.1%.
- the active ingredient extraction preparation method of the mild clean composition containing close to saturated, saturated or supersaturated active ingredients can be one of general high-temperature aqueous solution extraction, organic solvent extraction, ultrasonic extraction, or supercritical fluid extraction. One or more extraction combinations.
- the active ingredients of the mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients are based on the US Food and Drug Administration's Cosmetics Laws & Regulations: it can meet the definitions of cosmetics and drugs at the same time. It means that the present invention is any ingredient that has any function that can affect humans or other animals according to the purpose of scientific journals and intended use; and is used for human body cleaning, beauty, etc.
- the mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients has active ingredients that are intended to be used for rubbing, pouring, spraying or sprinkling, introducing or wiping onto the human body for cleansing, beautifying, and tightening.
- active ingredients that are intended to be used for rubbing, pouring, spraying or sprinkling, introducing or wiping onto the human body for cleansing, beautifying, and tightening.
- the mild cleansing composition containing nearly saturated, saturated, or super-saturated active ingredients means that its active ingredient means that its effect on the skin can be one of the following or a combination of effects, such as: whitening, promoting collagen synthesis , Anti-inflammatory, avoid skin dryness, anti-itch, anti-allergic, anti-aging, anti-oxidation, immune regulation, anti-fibrosis, etc.
- the mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients has O/W microemulsions (American Journal of Pharmtech Research, 2012), emulsions, or micelles (Cancers, July 2018) and other different dosage forms.
- liquid dosage forms containing fat-soluble and high physiological activity such as paclitaxel, paclitaxel, European paclitaxel and other drugs, which are effective for such needs.
- the therapeutic dose and the active ingredients that minimize the total volume of administration should be as close as possible to the solubility saturation of the active ingredients in the dosage form design; relatively, the active ingredients are nearly saturated, saturated, and supersaturated due to the characteristics of the active ingredients after being mixed with water. Disadvantages that are easy to precipitate.
- the present invention utilizes the near-saturated, saturated, and super-saturated characteristics of the active ingredients to convert this shortcoming into the advantages of external preparations, and achieves the precipitation and absorption of the effective ingredients after mixing with water, avoids being dissolved and washed out by detergents, and more
- the hydration effect of the cleanser on the skin is further added to increase the absorption and effect of the active ingredient.
- the present invention uses a mild surfactant combination, which mainly uses the principle of emulsification cleansing method to clean the skin and produce the stratum corneum hydration phenomenon. In this state, the stratum corneum not only increases Penetration also increases the capacity between the stratum corneum.
- the present invention uses this hydration phenomenon to increase the adhesion and penetration of the active ingredients to the stratum corneum at an appropriate time (The Journal of Investigative Dermatology, Vol. 101, No. 3, September 1993); At the same time, the concentration of active ingredients is close to saturation, saturation, or supersaturation (Pharmaceutical Research, July 2001, Volume 18, Issue 7, pp 1006-1011) to facilitate the deposition and adhesion of active ingredients and the difference in concentration Absorption produces protection and maintenance effects on the skin, and because of this novel design principle, it can also eliminate the possibility of excessive skin cleansing.
- Long-chain betaines (Handbook for Cleaning/Decontamination of Surfaces), sodium lauroyl sarcosinate (Cosmetic Ingredient Review, September 2016), sodium lauroyl hydroxymethyl ethanesulfonate ( Sodium lauroyl methyl isethionate) (Cosmetic Ingredient Review, September 2013) and potassium cocoyl glycinate (Cosmetic Ingredient Review, September 2013) are considered mild to the skin or eyes in various studies and scientific literature.
- a low-irritant surfactant The invention of a mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients is to apply this mild cleansing surfactant combination to gently cleanse the skin, and then according to the invention. Dissolve the active ingredients to a concentration close to saturation, saturation, or supersaturation, and at the same time achieve the effects of skin cleansing and skin care.
- the present invention provides a mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients, which includes at least one surfactant and at least one nearly saturated active ingredient.
- the surfactant is composed of long-chain betaines, sodium lauroyl sarcosinate, sodium lauroyl methyl isethionate, and potassium cocoyl glycinate (potassium cocoyl glycinate) any combination of one or more of them and accounted for 5.00wt% to 70.00wt% of the composition of the invention;
- the active ingredient consists of Angelica dahurica, Baiji, Atractylodes macrocephala, Bletilla striata, Poria cocos, Aconite, and comfrey.
- composition of the invention may further include an appropriate amount of water, which accounts for 15.00wt% to 85.00% of the composition of the invention;
- composition of the invention may further contain appropriate cosmetic excipients, such as diluents, thickeners, stabilizers, fragrances, preservatives, cosurfactants, etc., and the excipients account for 0 wt of the composition of the invention. % To 15.00wt%.
- the surfactant of the composition of the invention is long-chain betaines, sodium lauroyl sarcosinate, sodium lauroyl methyl isethionate , And potassium cocoyl glycinate (potassium cocoyl glycinate) in the composition of the invention are respectively 0wt% to 25.00wt%, 0wt% to 20.00wt%, 0wt% to 25.00wt%, 0wt% to 20.00wt%, and the sum thereof Must not be zero.
- the surfactant of the composition of the invention consists of long-chain betaines, sodium lauroyl sarcosinate, sodium lauroyl methyl isethionate ), and any combination of one or more of potassium cocoyl glycinate (potassium cocoyl glycinate) and account for 10.00 wt% to 65.00 wt% of the composition of the present invention.
- the surfactant of the composition of the invention consists of long-chain betaines, sodium lauroyl sarcosinate, sodium lauroyl methyl isethionate ), and any combination of one or more of potassium cocoyl glycinate (potassium cocoyl glycinate) and account for 20.00 wt% to 60.00 wt% of the composition of the present invention.
- the active ingredients of the composition of the invention are Angelica dahurica, Baiji, Baizhu, Bletilla striata, Poria cocos, aconite, and comfrey, which account for 0wt% to 8.00wt%, 0wt% to 8.00wt%, and 0wt% of the composition of the invention, respectively.
- the sum thereof must not be zero.
- the active ingredient of the composition of the invention is any combination of one or more of Angelica dahurica, Baiji, Baizhu, Bletilla striata, Poria cocos, aconite, and comfrey, and accounts for 0.10wt% to 8.00wt of the composition of the invention. %.
- the active ingredient of the composition of the invention is any combination of one or more of Angelica dahurica, Baiji, Atractylodes macrocephala, Bletilla striata, Poria cocos, aconite, and comfrey, and accounts for 0.20wt% to 6.00wt of the composition of the invention. %.
- the active ingredient of the composition of the invention is any combination of one or more of Angelica dahurica, Baiji, Baizhu, Bletilla striata, Poria cocos, aconite, and comfrey, and accounts for 0.40wt% to 4.00wt of the composition of the invention %.
- the composition of the invention may further comprise an appropriate amount of water, accounting for 20.00% to 80.00% by weight of the composition of the invention; more preferably, accounting for 25.00% to 75.00% of the composition of the invention; most preferably, accounting for the composition of the invention.
- the inventive composition is 30.00wt% to 70.00wt%.
- the composition of the invention may further include an appropriate amount of cosmetic excipients, which may be diluents, thickeners, stabilizers, fragrances, preservatives, or cosurfactants, etc.
- Excipients account for 0.50 wt% to 10.00 wt% of the inventive composition.
- the excipient accounts for 1.00% to 8.00% by weight of the composition of the invention. More preferably, the excipient accounts for 2.00% to 6.00% by weight of the composition of the invention. Most preferably, the excipient accounts for 4.00% to 6.00% by weight of the composition of the invention.
- the present invention provides a mild cleansing composition containing near-saturated, saturated, or super-saturated active ingredients, which includes at least one surfactant and at least one near-saturated, saturated, or super-saturated active ingredient that can improve skin texture.
- a maintenance composition wherein the mild cleansing composition is prepared by the following preparation method, the preparation method comprising the following steps: (i) adding the at least one active ingredient into a mixing container and adding an appropriate amount of water; and (ii) Add the at least one surfactant to the mixing container of step (i) and mix uniformly, if necessary, heat to dissolve and mix uniformly; (iii) if necessary, add appropriate excipients, such as diluents, thickeners, and stabilizers Agents, fragrances, or preservatives, etc., continue to mix well and return to room temperature.
- the mild clean composition containing nearly saturated, saturated, or supersaturated active ingredients and the active ingredients of the preparation method thereof can be obtained through general high-temperature aqueous solution extraction methods, organic solvent extraction methods, ultrasonic extraction methods, Or any combination of one or more of the supercritical fluid extraction methods.
- Figure 1 is a schematic diagram illustrating that the present invention utilizes surfactants and water to hydrate the stratum corneum, and the effective ingredients are implemented in a nearly saturated or saturated or supersaturated form to facilitate skin absorption.
- Figure 2 is a series of micrographs magnified at different magnifications, showing that the composition of the present invention is presented in different dosage forms.
- Figure 3 is a series of magnified microscope photographs at different magnifications, showing the precipitation state of Example 12 of the composition of the present invention before being mixed with water.
- Fig. 4 is a series of magnified micrographs of different magnifications, showing the precipitation state of Example 12 of the composition of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 10 minutes.
- Fig. 5 is a series of magnified micrographs of different magnifications, showing the precipitation state of Example 12 of the composition of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 60 minutes.
- Fig. 6 is a series of micrographs magnified at different magnifications, showing the precipitation state of Example 12 of the composition of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 360 minutes.
- Figure 7 is a series of magnified micrographs of different magnifications, showing the precipitation state of Example 12 of the composition of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 720 minutes.
- Fig. 8 is a micrograph of a magnified 200 times magnification, showing the state of the skin before being cleaned with a general cleanser.
- Fig. 9 is a micrograph of a magnified 200 times magnification, showing the state of the skin before washing in Example 10 of the composition of the present invention.
- Figure 10 is a 30-fold magnification microscope photograph showing the state of the skin being washed 20 times continuously with a general cleanser.
- Fig. 11 is a 30-fold magnification micrograph of a photomicrograph showing a state where the skin was washed 20 times continuously in Example 10 of the composition of the present invention.
- Figure 12 is a micrograph of a magnified 200 times magnification, showing the state of the skin being washed 20 times continuously with a general cleanser.
- FIG. 13 is a micrograph of a magnified 200 times magnification, showing a state where the skin was washed 20 times in Example 10 of the composition of the present invention.
- Figure 14 is a moisture retention test diagram illustrating the moisture retention of the skin in Example 11 of the composition of the present invention immediately after cleansing and 10 minutes after cleansing.
- Fig. 15 is a gloss detection graph, illustrating the gloss of the skin in Example 11 of the composition of the present invention immediately after cleansing and 10 minutes after cleansing.
- Fig. 16 is a series of magnified micrographs of different magnifications, showing the precipitation state of the composition of Comparative Example 13 of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 10 minutes.
- Fig. 17 is a series of magnified micrographs of different magnifications, showing the precipitation state of the composition of Comparative Example 13 of the present invention and water at a weight ratio of 1:1 after being uniformly mixed at a time point of 60 minutes.
- Fig. 18 is a 30-fold magnification microscope photograph showing the state of the skin before cleaning in Comparative Example 13 of the composition of the present invention.
- Fig. 19 is a 30-fold magnification micrograph, showing a state where the skin was washed 20 times continuously in Comparative Example 13 of the composition of the present invention.
- FIG. 20 is a micrograph of a magnified 200 times magnification, showing the state of the skin before cleaning in Comparative Example 13 of the composition of the present invention.
- FIG. 21 is a micrograph of a magnified 200 times magnification, showing a state where the skin was washed 20 times continuously in Comparative Example 13 of the composition of the present invention.
- the present invention provides a mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients.
- the composition contains one or more active ingredients. More than one active ingredient; and one or more than one surfactant; the inventive composition may further include an appropriate amount of water; the inventive composition may further include an appropriate amount of cosmetic excipients.
- FIG. 1 illustrate that the present invention utilizes surfactants and water to hydrate the stratum corneum 100, and the active ingredients are implemented in a nearly saturated, saturated, or supersaturated form in the combination of the present invention to make the active ingredients 200 easy to the surface of the stratum corneum. Precipitation is conducive to the absorption of active ingredients.
- the so-called having at least one surfactant is selected from the group consisting of long-chain betaines, sodium lauroyl sarcosinate, sodium lauroyl hydroxymethyl ethanesulfonate (sodium lauroyl sarcosinate). lauroyl methyl isethionate), and potassium cocoyl glycinate (potassium cocoyl glycinate), one or more of the above combinations.
- the so-called having at least one active ingredient is an extract selected from Angelica dahurica, Baiji, Atractylodes macrocephala, Bletilla striata, Poria cocos, Aconite, or Comfrey, one or more of them in any combination of the above.
- the embodiment of the present invention can have different dosage forms such as O/W microemulsion (American Journal of Pharmtech Research, 2012), emulsion, or micellar (Cancers, July 2018) according to different formulation combinations.
- O/W microemulsion American Journal of Pharmtech Research, 2012
- emulsion emulsion
- micellar micellar
- Example 1 Formulation 1 of a mild cleansing composition containing active ingredients and its manufacturing method
- every 1000 grams of the final product contains 5 grams of active ingredients.
- the manufacturing method is as follows: extract the active ingredients with a mixed extract of equal weight ratio of alcohol and water, wherein the mixed extract and each active ingredient
- the weight ratio of the ingredients of the raw materials is 10:1 to 50:1
- the extraction temperature is 50 to 100°C
- the extraction time is 1 hour to 10 hours.
- the extracted content contains 1000 mg each of Angelica dahurica, Baiji and Atractylodes striata, Bletilla striata, 500 mg extracts of Poria, Aconite, and Lithospermum erythrorhizon.
- Lauroyl methyl isethionate potassium cocoyl glycinate (potassium cocoyl glycinate) each 50 grams mixed with appropriate amount of water, if necessary, heat to a uniform state and add PEG-7 glyceryl cocoate (PEG-7 glyceryl cocoate), PEG-200 10 grams of PEG-200 hydrogenated glyceryl palmate (PEG-200 hydrogenated glyceryl palmate) are mixed uniformly, and then 10 grams of sodium chloride are added and mixed until uniform. After cooling to room temperature, it is obtained.
- Table 1 is the composition table of the formulation of Example 1.
- Examples 2 to 12 Formulations 2 to 12 of the mild cleansing composition containing active ingredients, the manufacturing method of which is similar to that of Example 1, but the different formulation composition and extraction method are also shown in Table 2.
- Table 2 is Examples 1 to 12 Formulation composition composition table, Table 3 shows the extraction methods of the active ingredients of the formulation compositions of Examples 1 to 12, and Table 4 shows the extraction conditions of each extraction method.
- the present invention provides a mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients, the test results of which are as follows:
- Example 12 Microscopically observe the composition of the present invention in Example 12 with a microscope, and mix the water and the composition of the present invention at a weight ratio of 1:1 uniformly, and observe with a microscope at the time points of 10, 60, 360, and 720 minutes.
- the saturated precipitation situation is shown in Figure 3 to Figure 7.
- the results showed that the composition of the present invention did not produce precipitation (Figure 3); water and the composition of the present invention were mixed uniformly in a weight ratio of 1:1, and a trace amount of precipitation visible under an optical microscope was generated at the time point of 10 minutes (Figure 4).
- Example 10 of the composition of the present invention were separately washed, wiped dry and then washed on the inner thigh for 20 consecutive cleaning procedures.
- the results are shown in Table 5 and Figures 8 to 13 to avoid excessive cleaning. The experiment shows.
- the experiment uses gloss and microscopy as observation tools to simulate general washing methods for cleaning.
- the results show that the skin surface is damaged after repeated cleaning with general detergents in a short period of time.
- the microscopy results also show that the stratum corneum is damaged and white peeling.
- the microscopic results of this microscopic examination also show a decrease in the macroscopic gloss detection results; on the contrary, the skin surface is not only not damaged after repeated washing in a short period of time using the composition of the present invention.
- Observing the results of microscopy the difference between before and after washing cannot be distinguished, but the improvement of skin smoothness can be seen from the results of gloss. Based on this, it can be expected that long-term use of the composition of the present invention will make the skin more delicate and smooth, and further lead to a large gloss. Raised to the point where the human eye can discern the difference.
- the use of cleansing agents to clean the skin easily damages the stratum corneum and causes the skin surface to be rough, and then based on the use of skin care products such as creams on the damaged skin; relatively, the composition of the present invention Utilizing a design that is close to saturation, saturation, or supersaturation, the effective ingredients can be precipitated, absorbed and protected from damage during the process of cleansing the skin.
- Example 11 the standard steps are one decontamination and one cleaning and maintenance every time you wash your face. Every time you clean your face, it is measured with a commercially available skin detector (RUNVE Skin Analyzer).
- This detector contains three measurement values: humidity, Oil content and fine roughness, of which oil content and fine roughness can be tested with skin gloss; moisture content is represented by the average value of three-point detection of forehead and left and right cheekbones.
- the composition of the present invention is used to clean the skin for more than 4 weeks in accordance with the above-mentioned standard use steps. It can be seen from its moisture retention test chart ( Figure 14). Whether it was just after cleansing or 10 minutes after cleansing, the moisture retention index showed a significant improvement after two weeks.
- the moisturizing degree of cleansing products after cleaning is about 40 to 42, and the degree of moisturizing after drying is about 34 to 38.
- Table 6 referring to the classification of moisturizing degree in the instruction manual, it can be seen that it falls in the normal skin area after cleansing, 10 minutes The moisture is lost to the dry skin area; relatively, after using the composition of the present invention for about two weeks, the moisturizing degree after cleansing is about 43 to 48, and the moisturizing degree after drying is about 38 to 44.
- the skin test According to the classification of the moisturizing degree of the device manual, it can be known that after cleansing, it falls in the range of skin full of suitable humidity, and the water is lost to the range of normal skin in 10 minutes.
- the general dermatologist’s perception of skin gloss is that the oil secreted by the sebaceous glands and other substances in the environment will increase the gloss of the skin (Biomedical Optics Express). This environment produced on the skin can easily lead to acne and seborrhoea.
- skin diseases such as dermatitis; relatively, when the skin is cleaned without the interference of the above-mentioned sebum, the skin still shows obvious gloss is due to the long-term healthy skin composition, such as reducing skin roughness (Skin Research and Technology), wrinkle reduction, and better moisturizing performance for delicate and healthy skin.
- Such performance can be promoted by, for example, epidermal growth factor or collagen proliferation (WO2005037270A1).
- the composition of the present invention is rich in active ingredients enough to promote healthier skin, thereby reducing wrinkles, etc., thereby increasing the gloss of the skin after cleansing (International Journal of Research in Pharmacy and Chemistry).
- the standard steps are one decontamination and one cleaning and maintenance every time you wash your face. After cleaning every day, use BYK Micro-Gloss to detect the skin glossiness of the forehead in the flattest area of the face. After about 3 weeks of cleaning (Dermisa Brightening Bar) with general facial cleansing products, cleaning and testing, and then cleaning the skin with the composition of the present invention in accordance with the above-mentioned standard use steps for more than 4 weeks, according to the gloss test chart ( Figure 15), you can see the cleansing Whether it was just after cleaning or 10 minutes after cleaning, the gloss index showed a significant improvement after two weeks.
- the gloss of sebum-containing people's face is about 2GU (Gloss Unit). After cleansing or the roughness of the skin will decrease to about 1GU, it will also increase to 2.5GU with the increase of skin fineness or the use of maintenance cosmetics. Left and right (Optical Review).
- the composition of the present invention can reach a gloss of about 3GU to 5GU after long-term use and before using various skin care products, so that the human eye can distinguish the difference in gloss (the human eye can distinguish the difference of about 3GU), so generally The user can also clearly feel the skin's fineness and see the increase in gloss. After cleansing, the hydrated skin is not yet dry and the stratum corneum has not returned to its original state, so the gloss is about 3GU. After 10 minutes of recovery, the gloss can normally appear to about 5GU.
- Comparative Example 13 Formula 13 of a mild cleansing composition containing unsaturated active ingredients and its manufacturing method
- every 1000 grams contains 0.83 grams of active ingredients.
- the manufacturing method is as follows: extract the extracts with equal proportions of alcohol and water respectively, containing 100 mg of Angelica dahurica, Baiji and Atractylodes macrocephala, Bletilla striata, Poria cocos , Aconite, and comfrey each 50 mg extract, and cocamidopropyl betaine (cocamidopropyl betaine), sodium lauroyl sarcosinate (sodium lauroyl sarcosinate), sodium lauroyl hydroxymethyl ethanesulfonate (sodium Lauroyl methyl isethionate), potassium cocoyl glycinate (potassium cocoyl glycinate), 50 grams each, mixed with an appropriate amount of water, if necessary, heat to a uniform state and add PEG-7 glyceryl cocoate (PEG-7 glyceryl cocoate), PEG-200 10 grams of PEG-200 hydrogenated g
- This comparative example provides a mild cleansing composition containing unsaturated active ingredients.
- the comparative test results are as follows:
- the experiment used gloss and microscope inspection as observation tools to simulate general washing methods for cleaning.
- the results showed that the skin surface of Comparative Example 13 did not change significantly after repeated washing in a short period of time; although the gloss result (washing) 1.4GU before and 1.4GU after washing) showed that the skin smoothness did not change significantly, and the microscopic examination results failed to see a significant difference in the cell types before and after washing, but under the microscope: the gloss after washing was still higher than Lower before cleaning.
- the saturated example 10 not only has the function of avoiding excessive cleansing and protection of the skin, but also can increase the smoothness of the skin; on the contrary, no The function of Saturated Example 13 to avoid excessive cleansing and protection of the skin is not significant.
- This experiment shows that the invention of the mild cleansing composition containing nearly saturated, saturated, or supersaturated active ingredients has its special novelty and progress.
Abstract
Description
数位格数 | 1 | 2 | 3 | 4 | 5 |
含水百分比 | ≦33% | 34%~37% | 38%~42% | 43%~46% | ≧47% |
保湿度 | 干燥 | 轻微干燥 | 正常保湿 | 保湿良好 | 极度保湿 |
Claims (20)
- 一种温和洁净组合物,其特征在于:包括:至少一种界面活性剂;以及至少一接近饱和、饱和、或超饱和且可改善皮肤质地的活性成分。
- 根据权利要求1所述的温和洁净组合物,其特征在于:所述界面活性剂含有长链甜菜碱、月桂酰肌氨酸钠、月桂酰羟甲基乙磺酸钠、及椰油酰甘氨酸钾中至少一者,且所述界面活性剂占所述温和洁净组合物5wt%至70wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:所述界面活性剂含有长链甜菜碱、月桂酰肌氨酸钠、月桂酰羟甲基乙磺酸钠、及椰油酰甘氨酸钾中至少一者,且所述界面活性剂占所述温和洁净组合物10wt%至65wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:所述活性成分含有白芷、白蔹、白术、白芨、茯苓、附子、及紫草中至少一者的萃取物,且所述活性成分占所述温和洁净组合物0.1wt%至10wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:所述活性成分含有白芷、白蔹、白术、白芨、茯苓、附子、及紫草中至少一者的萃取物,且所述活性成分占所述温和洁净组合物0.2wt%至6wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:还包括水。
- 根据权利要求6所述的温和洁净组合物,其特征在于:所述适量水占所述温和洁净组合物20wt%至80wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:还包括化妆品赋形剂。
- 根据权利要求8所述的温和洁净组合物,其特征在于:所述化妆品赋形剂占所述温和洁净组合物0.50wt%至10.00wt%。
- 根据权利要求1所述的温和洁净组合物,其特征在于:所述活性成分的萃取物的制备方法为一般高温水性溶液萃取法、有机溶媒萃取法、超音波萃取法、或超临界流体萃取法。
- 一种温和洁净组合物,其特征在于,包括:至少一界面活性剂,选自长链甜菜碱、月桂酰肌氨酸钠、月桂酰羟甲基乙磺酸钠、及椰油酰甘氨酸钾中至少一种;以及至少一接近饱、饱和、或超饱和且可改善皮肤质地的活性成分,选自白芷、白蔹、白术、白芨、茯苓、附子、及紫草中至少一种的萃取物。
- 根据权利要求11所述的温和洁净组合物,其特征在于:选自长链甜菜碱、月桂酰肌氨酸钠、月桂酰羟甲基乙磺酸钠、及椰油酰甘氨酸钾中至少二者,且所述界面活性剂占所述温和洁净组合物5wt%至70wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:所述界面活性剂含有长链甜菜碱、月桂酰肌氨酸钠、月桂酰羟甲基乙磺酸钠、及椰油酰甘氨酸钾中至少二者,且所述界面活性剂占所述温和洁净组合物10wt%至65wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:所述活性成分含有白芷、白蔹、白术、白芨、茯苓、附子、及紫草中至少二者的萃取物,且所述活性成分占所述温和洁净组合物0.1wt%至10wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:所述活性成分含有白芷、白蔹、白术、白芨、茯苓、附子、及紫草中至少二者的萃取物,且所述活性成分占所述温和洁净组合物0.2wt%至6wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:还包括水。
- 根据权利要求16所述的温和洁净组合物,其特征在于:所述水占所述温和洁净组合物20wt%至80wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:还包括化妆品赋形剂。
- 根据权利要求18所述的温和洁净组合物,其特征在于:所述化妆品赋形剂占所述温和洁净组合物0.50wt%至10.00wt%。
- 根据权利要求11所述的温和洁净组合物,其特征在于:所述活性成分的萃取物的制备方法为一般高温水性溶液萃取法、有机溶媒萃取法、超音波萃取法、或超临界流体萃取法。
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3171372A CA3171372A1 (en) | 2020-02-19 | 2020-02-19 | Mild cleansing composition containing nearly saturated, saturated or supersaturated active ingredients and preparation method therefor |
CN202080096376.0A CN115867257A (zh) | 2020-02-19 | 2020-02-19 | 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 |
KR1020227030252A KR20220145840A (ko) | 2020-02-19 | 2020-02-19 | 거의 포화, 포화, 또는 초포화 활성성분을 함유하는 순한 클렌징 조성물 및 이의 제조방법 |
AU2020430275A AU2020430275A1 (en) | 2020-02-19 | 2020-02-19 | Mild cleansing composition containing nearly saturated, saturated or supersaturated active ingredients and preparation method therefor |
PCT/CN2020/075824 WO2021163915A1 (zh) | 2020-02-19 | 2020-02-19 | 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 |
JP2022549369A JP2023516566A (ja) | 2020-02-19 | 2020-02-19 | ほぼ飽和、飽和、または過飽和の活性成分を含む温和な清浄化組成物及びその製造方法 |
US17/799,784 US20230091703A1 (en) | 2020-02-19 | 2020-02-19 | Mild cleansing composition containing nearly saturated, saturated or supersaturated active ingredients and preparation method therefor |
EP20919388.7A EP4108229A4 (en) | 2020-02-19 | 2020-02-19 | MILD CLEANING COMPOSITION CONTAINING QUASI-SATURATED, SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND ASSOCIATED PREPARATION METHOD |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2020/075824 WO2021163915A1 (zh) | 2020-02-19 | 2020-02-19 | 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021163915A1 true WO2021163915A1 (zh) | 2021-08-26 |
Family
ID=77390356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/075824 WO2021163915A1 (zh) | 2020-02-19 | 2020-02-19 | 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230091703A1 (zh) |
EP (1) | EP4108229A4 (zh) |
JP (1) | JP2023516566A (zh) |
KR (1) | KR20220145840A (zh) |
CN (1) | CN115867257A (zh) |
AU (1) | AU2020430275A1 (zh) |
CA (1) | CA3171372A1 (zh) |
WO (1) | WO2021163915A1 (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037270A1 (en) | 2003-10-17 | 2005-04-28 | Lg Household & Health Care Ltd. | Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
CN102198078A (zh) * | 2011-05-23 | 2011-09-28 | 昆明理工大学 | 一种含中药的泡沫型洗面奶及其制备方法 |
CN102198067A (zh) * | 2011-05-31 | 2011-09-28 | 云南健牛生物科技有限公司 | 一种含盐药用沐浴液及其制备方法 |
CN102895316A (zh) * | 2012-10-23 | 2013-01-30 | 深圳市英杰汇生物科技有限公司 | 一种治疗、预防痤疮的洁面剂及其制备方法 |
CN103655448A (zh) * | 2013-12-20 | 2014-03-26 | 广西柳州浚业科技有限公司 | 含红石榴的中草药洗面奶及其制备方法 |
CN104523541A (zh) * | 2014-12-08 | 2015-04-22 | 罗昕 | 一种美白洗面奶 |
CN104546607A (zh) * | 2014-12-25 | 2015-04-29 | 刘三猫 | 一种制备中药沐浴露的组合物和该沐浴露及其制备方法 |
CN108186440A (zh) * | 2018-02-09 | 2018-06-22 | 深圳翰承生物医药科技有限公司 | 可抗菌护肤的中药植物沐浴露及其制备方法和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040686A (zh) * | 2012-12-17 | 2013-04-17 | 青岛红星化工集团自力实业公司 | 一种湿巾 |
CN109528566B (zh) * | 2019-01-22 | 2021-01-05 | 宜春学院 | 一种中药抑菌洗手液及其制备方法 |
-
2020
- 2020-02-19 AU AU2020430275A patent/AU2020430275A1/en active Pending
- 2020-02-19 WO PCT/CN2020/075824 patent/WO2021163915A1/zh unknown
- 2020-02-19 US US17/799,784 patent/US20230091703A1/en active Pending
- 2020-02-19 KR KR1020227030252A patent/KR20220145840A/ko unknown
- 2020-02-19 CA CA3171372A patent/CA3171372A1/en active Pending
- 2020-02-19 JP JP2022549369A patent/JP2023516566A/ja active Pending
- 2020-02-19 EP EP20919388.7A patent/EP4108229A4/en active Pending
- 2020-02-19 CN CN202080096376.0A patent/CN115867257A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037270A1 (en) | 2003-10-17 | 2005-04-28 | Lg Household & Health Care Ltd. | Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
CN102198078A (zh) * | 2011-05-23 | 2011-09-28 | 昆明理工大学 | 一种含中药的泡沫型洗面奶及其制备方法 |
CN102198067A (zh) * | 2011-05-31 | 2011-09-28 | 云南健牛生物科技有限公司 | 一种含盐药用沐浴液及其制备方法 |
CN102895316A (zh) * | 2012-10-23 | 2013-01-30 | 深圳市英杰汇生物科技有限公司 | 一种治疗、预防痤疮的洁面剂及其制备方法 |
CN103655448A (zh) * | 2013-12-20 | 2014-03-26 | 广西柳州浚业科技有限公司 | 含红石榴的中草药洗面奶及其制备方法 |
CN104523541A (zh) * | 2014-12-08 | 2015-04-22 | 罗昕 | 一种美白洗面奶 |
CN104546607A (zh) * | 2014-12-25 | 2015-04-29 | 刘三猫 | 一种制备中药沐浴露的组合物和该沐浴露及其制备方法 |
CN108186440A (zh) * | 2018-02-09 | 2018-06-22 | 深圳翰承生物医药科技有限公司 | 可抗菌护肤的中药植物沐浴露及其制备方法和用途 |
Non-Patent Citations (12)
Title |
---|
AMERICAN JOURNAL OF PHARMTECH RESEARCH, 2012 |
CANCERS, July 2018 (2018-07-01) |
CLINICS IN DERMATOLOGY, vol. 14, January 1996 (1996-01-01), pages 29 - 33 |
CURRENT PHARMACEUTICAL DESIGN, vol. 21, no. 00, 2015 |
INDIAN J DERMATOL, vol. 56, no. 1, January 2011 (2011-01-01), pages 2 - 6 |
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY |
JOURNAL OF PHARMACEUTICAL SCIENCES, January 2012 (2012-01-01) |
PHARMACEUTICAL RESEARCH, vol. 18, July 2001 (2001-07-01), pages 1006 - 1011 |
PHYSICOCHEMICAL AND ENGINEERING ASPECTS, vol. 74, 1993, pages 169 - 215 |
See also references of EP4108229A4 |
SKIN PHARMACOL PHYSIOL, vol. 19, 2006, pages 106 - 21 |
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 101, no. 3, September 1993 (1993-09-01) |
Also Published As
Publication number | Publication date |
---|---|
CA3171372A1 (en) | 2021-08-26 |
CN115867257A (zh) | 2023-03-28 |
US20230091703A1 (en) | 2023-03-23 |
EP4108229A4 (en) | 2023-11-22 |
AU2020430275A1 (en) | 2022-09-15 |
EP4108229A1 (en) | 2022-12-28 |
KR20220145840A (ko) | 2022-10-31 |
JP2023516566A (ja) | 2023-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI652066B (zh) | 用於使皮膚回春之胜肽及其使用方法 | |
JP7309620B2 (ja) | 皮膚及び/又は粘膜を水和させるためのネフェリウム・ラパセウム(nephelium lappaceum)の果皮の抽出物の使用 | |
CN105687059A (zh) | 一种用于抗衰老的化妆品组合物及其配制方法、应用 | |
CN108685734A (zh) | 一种无硫酸盐无硅低刺激温和植物养发香波 | |
JP2022511023A (ja) | シスツス・モンスペリエンシス(Cistus monspeliensis)の抽出物の新規な化粧品的及び皮膚科学的使用 | |
TWI229605B (en) | Cosmetic method | |
KR20180053318A (ko) | 피부 수화 또는 보습을 향상시키기 위한 접근법 | |
JP5765744B2 (ja) | アトピー性皮膚炎の予防剤または治療剤、および外用剤 | |
KR102209847B1 (ko) | 피부 보습 및 진정용 기능성 화장료 조성물 | |
JP4080946B2 (ja) | 皮膚外用剤 | |
JP2022548757A (ja) | 皮膚欠陥を予防、低減、又は排除し、皮膚疾患を治療し、及び頭皮の過剰に脂漏性である状態を予防、治療、及び抑制するための、コハク酸を含む、メイクアップを洗浄及び/又は除去するための化粧品又は皮膚科学組成物 | |
BR112018006383B1 (pt) | Composição de limpeza trifásica e seus métodos de preparação e uso | |
WO2021163915A1 (zh) | 含接近饱和、饱和、或超饱和活性成分的温和洁净组合物及其制备方法 | |
TWI807133B (zh) | 含接近飽和、飽和、或超飽和活性成分的溫和潔淨組合物及其製備方法 | |
TWI815335B (zh) | 含超飽和活性成分的溫和潔淨組合物及其用途與製備方法 | |
KR101734801B1 (ko) | 추출물들의 조합을 이용한 피부 노화 징후 감소 방법 | |
KR101734802B1 (ko) | 피부 노화의 징후를 감소시키기 위한 추출물의 조합을 포함하는 국소 조성물 | |
JP2009234986A (ja) | 相乗効果水を含有する皮膚外用剤 | |
CN117083051A (zh) | 不含硫酸盐衍生型表面活性剂的新型局部用组合物 | |
TW201717990A (zh) | Cnp環狀胜肽及含此環狀胜肽之醫藥品、外用劑及化粧品 | |
US8790710B1 (en) | Topical composition comprising umbilical cord blood serum | |
Rokade et al. | Formulation and development of herbal facewash using Beal leaves: Aegle marmelos | |
JP2004352630A (ja) | 皮膚外用剤 | |
JP2000109420A (ja) | 老化用の化粧料 | |
WO2024056566A1 (en) | Use of thioethylamine composition for skin rejuvenation and improved synergistic effect when combined with an organic acid and/or azabenzene-4-carboxamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20919388 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022549369 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3171372 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2020430275 Country of ref document: AU Date of ref document: 20200219 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020919388 Country of ref document: EP Effective date: 20220919 |